Industry News
Genetic study hones in on causes of MS
29 genes influencing multiple sclerosis (MS) have been uncovered in an international GWAS study, showing the immune system and T cells play a crucial role in the disease. [ + ]
Many genes make you smart
New insight into the genetic basis of intelligence shows that many small variations contribute to someone's intelligence. [ + ]
Free seminar on optical scanning
Rheology Solutions and Optical Control Systems (OCS) are running a free joint workshop on optical scanning on Tuesday 6 September 2011.
[ + ]Cochlear posts 16% jump in profit for FY11
Proving that market jitters don’t necessarily reflect underlying profitability, Cochlear has posted a 10% increase in revenue and 16% jump in profit for FY11. [ + ]
Market watch: Biotechs take battering as markets lurch
Biotechnology stocks haven’t been spared the tumult of the market with several falls of over 5% today. [ + ]
New molecules offer hope for treating HIV and cancer
The discovery of two molecules that block endocytosis opens up the possibility of selectively preventing viruses like HIV from infecting cells and for halting the growth of cancers. [ + ]
Bionomics to extend trials of ovarian cancer treatment
Trials of BNC105 in combination with existing chemotherapy drugs to treat ovarian cancer. [ + ]
Funding to commercialise new needle-free vaccine delivery technology
OneVentures and Vaxxas Pty Ltd investment will enable Professor Mark Kendall of UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) to continue his pioneering research and development of the Nanopatch.
[ + ]Nobel Prize winner to strengthen national science body
Nobel Prize winner Professor Peter Doherty will join the National Science Colloquium of the Australian Synchrotron.
[ + ]Vaxxas gets $15m injection to develop needle-free vaccine
Biotech start-up Vaxxas has received a $15m venture capital kick start to commercialise needle-free vaccine delivery system Nanopatch. [ + ]
Agilent Technologies appoints three NMR/MRI experts
Agilent Technologies has announced three new appointments as part of its business strategy to invest and further develop its nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) portfolio, providing greater support to its customers in the South Asia Pacific and Korea (SAPK) region.
[ + ]Plasvacc pulls out of sale to Bioniche
The proposed acquisition of Plasvacc by Bioniche has been kyboshed, with Plasvacc walking away from the deal after negotiations "collapsed". [ + ]
Feature: Functional genomics writ large
Sequencing the human genome was the easy part. Determining the function of 23,000 human genes is a far greater challenge. The Diamantina’s new high-throughput functional genomics facility will help accelerate the process. [ + ]
